ClinicalTrials.gg
Not yet recruitingNCT07790588Updated Aug 27, 2026

Project Leo: Trauma-Informed Yoga for Preschool Children and Parents

An interventional study of Dyadic (Child-Parent) Yoga in Post Traumatic Concerns, sponsored by Florida Atlantic University. Not yet recruiting at 2 sites in 2 countries. Open to participants aged 3 Years and older. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Florida Atlantic University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Not applicable
Ages
3 Years and older
Sex
All
01

Study summary

The goal of this pilot clinical trial is to examine feasibility, acceptability, and direction of effect of a dyadic (child and parent) trauma-informed yoga intervention on stress symptoms and sleep in young children (age 3-6) after war. The main questions it aims to answer are:

  • Is the intervention feasible and liked by the participants?
  • Does the child-parent yoga intervention reduce the child's stress symptoms and improve their sleep?
  • Does the child-parent yoga intervention improve the child-parent relationship?

Participants (child-parent dyads) will:

  • Children and parents will participate together in 8 weekly group yoga sessions.
  • Children and parents will engage together in a short daily at-home practice before bedtime.
  • Parents will complete online surveys before and after the 8-week program, and at one-month follow-up.
  • Parents will complete a daily practice-sleep log.
02

Conditions studied

  • Post Traumatic Concerns

Keywords

  • Post-trauma
  • Children
  • Yoga
  • Child-Parent Dyad
03

In context

Lead sponsor

Florida Atlantic University is the lead sponsor of 36 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Children: Age 3-6. Per the parent's report, the child exhibits at least one stress-related symptom.

Parents: Preferably, the same parent can attend all group sessions. Having internet access at home to complete online surveys.

Exclusion criteria

Exclusion Criteria:

Children: Any physical disability that prevents participating safely in yoga sessions.

Parents: Self-reported pregnancy. Any physical disability that prevents participating safely in gentle yoga sessions.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    Intervention

    Dyadic (Child-Parent) Yoga

    Behavioral: Dyadic (Child-Parent) Yoga

Interventions

  • BehavioralDyadic (Child-Parent) Yoga

    Participants will attend 8 weekly group sessions of dyadic (child and parent) yoga and engage in at-home practice at bedtime.

06

What researchers measure

Primary outcomes

  1. Child's Stress Symptoms

    Presence and severity of stress symptoms will be assessed (parent-reported) using the Young Child PTSD Checklist (YCPC). The 30-item scale yields a sum score ranging from 0 to 120, with higher scores indicating more severe stress symptoms.

    Time frame: 8 weeks

  2. Child's Sleep Quality

    The child's sleep quality will be assessed (parent-reported) using the Children's Sleep Habits Questionnaire Abbreviated (CSHQ). The 22-item scale yields a sum score ranging from 0 to 88, with higher scores indicating more severe sleep problems.

    Time frame: 8 weeks

Secondary outcomes

  1. Child-Parent Relationship: Closeness

    The quality of the child-parent relationship will be assessed (parent-reported) using the Child-Parent Relationship Scale - Short Form (CPRS-SF), specifically the Closeness subscale. The 7-item subscale yields a sum score of 7 to 35, with higher scores indicating greater closeness. Higher closeness scores reflect better relationship between the child and the parent.

    Time frame: 8 weeks

  2. Child-Parent Relationship: Conflict

    The quality of the child-parent relationship will be assessed (parent-reported) using the Child-Parent Relationship Scale - Short Form (CPRS-SF), specifically the Conflict subscale. The 8-item subscale yields a sum score of 8 to 40, with higher scores indicating greater conflict. Lower conflict scores reflect better relationship between the child and the parent.

    Time frame: 8 weeks

  3. Parent's Stress Symptoms

    Presence and severity of post-traumatic stress symptoms will be assessed (self-reported) using the PCL-5 scale. The 20-item scale yields a sum score ranging from 0 to 80, with higher scores indicating more severe post-traumatic stress symptoms.

    Time frame: 8 weeks

  4. Parent's Sleep Quality

    The parent's sleep quality will be assessed (self-reported) using the Sleep Disturbance PROMIS SF 8b. The 8-item scale yields a sum score ranging from 8 to 40, with higher scores indicating more severe sleep problems.

    Time frame: 8 weeks

  5. Parental Self-Efficacy

    The parent's self-confidence in their ability to handle their child's behavior problems will be assessed (self-reported) by the Brief Parental Self-Efficacy Scale. The 5-item scale yields a sum score ranging from 5 to 20, with higher scores indicating greater self-confidence.

    Time frame: 8 weeks

  6. Child's Pain Severity

    If the child experiences pain, pain severity will be assessed (parent-reported) using one item from the Brief Pain Inventory (BPI). Pain severity will be rated on a scale from 0 to 10, with higher rating indicating more severe pain.

    Time frame: 8 weeks

  7. Child's Pain Interference

    If the child experiences pain, pain interference with routine activities will be assessed (parent-reported) using one item from the Brief Pain Inventory (BPI). The level of how much the pain interferes with routine activities will be rated on a scale from 0 to 10, with higher ratings indicating greater interference.

    Time frame: 8 weeks

  8. Parent's Pain Severity

    If the parent experiences pain, pain severity will be assessed (self-reported) using one item from the Brief Pain Inventory (BPI). Pain severity will be rated on a scale from 0 to 10, with higher rating indicating more severe pain.

    Time frame: 8 weeks

  9. Parent's Pain Interference

    If the parent experiences pain, pain interference will be assessed (self-reported) using two items from the Brief Pain Inventory (BPI). The level of how much the pain interferes with (a) enjoyment in life and with (b) routine activities will be rated on a scale from 0 to 10, with higher ratings indicating greater interference.

    Time frame: 8 weeks

Other outcomes

  1. Feasibility: Recruitment

    Recruitment will be calculated as the proportion of enrolled participants to interested individuals during the recruitment period.

    Time frame: Recruitment period, from initiation until the start day of the intervention

  2. Feasibility: Intervention Retention

    Retention will be calculated as the proportion of participants who completed the intervention to participants who gave their consent to participate.

    Time frame: 8 weeks

  3. Feasibility: Intervention Adherence

    Percentage of participants completing at least 75% of the group sessions AND at least 4 at-home practices per week. Group session attendance will be monitored by the research team. At-home practice will be self-reported via a daily practice log.

    Time frame: 8 weeks

  4. Acceptability: Liking

    Parents will be asked if they liked the intervention on a scale of 0 to 10, with higher ratings indicating greater liking and better acceptability of the intervention among parents.

    Time frame: 8 weeks

  5. Acceptability: Recommending

    Parents will be asked about the likelihood that they would recommend the program to others, rated from 0 to 100%, with higher ratings indicating a greater likelihood of recommending the intervention and better acceptability of the intervention among parents.

    Time frame: 8 weeks

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Feb 2027, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 19, 2026
First posted
Aug 27, 2026
StartEst.
Oct 5, 2026
Primary completionEst.
Feb 10, 2027
CompletionEst.
Mar 2027
Last update
Aug 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07790588
Lead sponsor
Florida Atlantic University
Collaborators
Tel Aviv University
Responsible party
Shahar Almog (Senior Research Fellow, Florida Atlantic University) — Principal investigator
First posted
Aug 27, 2026
Start date
Oct 5, 2026 (estimated)
Primary completion
Feb 10, 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Aug 27, 2026

Study contacts

Shahar Almog, PhD
Contact
salmog@fau.edu
+1 (561) 2973461
Noga Tsur, PhD
Contact
nogatsur@tauex.tau.ac.il
Shahar Almog, PhD
principal investigator · Florida Atlantic University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion